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The risk of osteoporosis depends largely upon the 
peak bone mass acquired during early adulthood 
against the rate of bone loss occurring later in life. A 
poor intake of calcium and vitamin D, physical 
inactivity and prolonged amenorrhea are among the 
factors that can severely diminish peak bone mass. 
Females having low peak bone mass are more liable 
to suffer from osteoporosis at the time of menopause. 
A number of risk factors are known to be involved in 
the pathogenesis of osteoporosis (table 1). The most 
important risk factors include female gender, 
Caucasian or Asian ethnicity, early menopause, 
previous low trauma fracture, family history of 
osteoporosis in first degree relatives, current 
smoking and low body mass index. Additional 
factors include chronic illness, endocrine disorders, 
excessive alcohol intake and use of certain drugs 
notably steroids. It is important to emphasise that 
none of the risk factors predict bone mass with 
sufficient accuracy in an individual patient. The best 
combination of risk factors only accounts for about 
20 per cent of the variability in bone mass. Clinical 
risk factors thus add information about the risk of 
osteoporosis, which is only partly explained by 
variation in bone mass. They should therefore 
preferably be used to target individuals for further 
investigations (which include bone densitometry 
and biochemical markers of bone turnover), and 
treatment (table 2).
The definition of osteoporosis is based on bone 
densitometry. Normal bone mass is defined as a bone 
mineral density (BMD) above or below 1 SD from 
the premenopausal mean value.  Osteopenia is BMD 
between -1SD and -2.5 SD while osteoporosis is 
BMD below -2.5 SD. These criteria reflect the fact 
that bone mass accounts for 75-85 per cent of the 
variability in ultimate bone strength, it is considered 
as one of the best single predictors of fracture risk 
and low bone mass is an important risk factor for 
osteoporosis.
Dr Aysha Habib Khan
Chemical Pathology
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Assessment of Osteoporosis Risk by NTx- A 
Biochemical Marker
Age 
Previous fragility fracture
Endocrine
• Premature menopause
• BMI < 20
• Previous Ammenorrhea (> 6 months duration)
Genetics
• Low trauma fracture in first degree relative
• Caucasian or Asian ethnicity
• Female gender
Lifestyle
• Low level of physical activity
• Poor calcium intake (< 0.5 g/day)
• Alcohol excess (> 14 units/week)
• Cigarette smoking
Table 1: Risk Factor of Osteoporosis
Low bone mass together with a high rate of bone loss 
further increases the risk of fracture. High bone 
turnover as estimated by biochemical markers is 
associated with an increased rate of bone loss and 
predicts the risk of fracture independently of BMD. 
Studies have reported odds ratio for fracture of 
around 2 per 2 SD increase in the biochemical 
marker above the premenopausal mean value. In 
these studies, the biochemical markers with the best 
predictive accuracy were urine C- and N-
telopeptides of type I collagen and urine deoxy 
pyridinoline, all known to be biochemical markers of 
bone resorption.
It is significant that a bone mass in the osteoporotic 
range and an increased value of a biochemical 
marker increase the odds ratio for hip fracture to 4-5, 
suggesting that combined information on bone 
densitometry and biochemical markers improves the 
estimation of osteoporosis risk.
The biochemical marker of bone turnover that we 
have introduced in our laboratory is N-terminal 
telopeptide of type I collagen (NTx). It is measured 
by a competitive-inhibition enzyme-linked 
immunosorbent assay. Studies support the use of 
NTx to monitor the anti-resorptive effect of therapy 
and to determine the probability for a decrease in 
BMD i f  therapy  i s  no t  in i t i a ted .  The  
recommendation for monitoring therapy is to have 
baseline samples just prior to or on the day of therapy 
initiation. Subsequent specimens for comparison 
should be collected at approximately the same time 
of day as the baseline specimen.
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Target individuals for further investigation
• Densitometry
• Bone turnover markers
Eliminate modifiable risk factors
Discuss Treatment
• Advantages
• Disadvantages
Table 2: Use of Risk Factors in Management
Antibodies Against Cyclic Citrullinated 
Peptides (Anti-CCP) Assay in Rheumatoid 
Arthritis 
Rheumatoid arthritis (RA) is one of the most 
common autoimmune diseases, affecting 0.5-1 per 
cent of the world population. This systemic disease is 
characterised by chronic inflammation of the 
synovial joints and progressive joint degeneration 
causing pain, joint destruction and impaired joint 
mobility and eventually leading to loss of function 
and disability of the affected individuals. Figure 1 
shows differences between a healthy and damaged 
joint.  Early and aggressive intervention with new 
and effective biological and targeted treatments can 
alter the course of the disease and improve overall 
quality of life. This suggests that improved markers 
for diagnosis and prognosis are needed to identify 
these patients at an earlier stage and modify the 
available therapeutic choices according to the 
individual patient's needs.
The diagnosis of RA often relies on clinical 
manifestations and laboratory tests such as 
erythrocyte sedimentation rate (ESR), rheumatoid 
factor (RA-Factor) and C-reactive protein (CRP). 
Ms Shahmina Sadaf
Haematology
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However, RA-Factor is a non-specific marker and 
may be present in healthy persons or in patients with 
other autoimmune and infectious diseases while 
CRP is a non-specific inflammatory marker. A new 
laboratory test for diagnosing RA by measuring 
antibodies against cyclic citrullinated peptides (anti-
CCP) has recently become available. 
Anti-CCP is a quantitative determination of human 
IgG autoantibodies against cyclic citrullinated 
peptides in the human serum. It involves the IgG 
capture principle by utilising the electro-
chemiluminescence methodology on fully 
automated immunoassay analysers 
(Figure 2). The assay has the sensitivity of 
67.4 per cent and specificity 97.0 per cent 
using a cut-off of 17 U/mL.
The antibodies are directed against the 
circular peptide containing an amino acid 
called citrulline.  Citrullination refers to 
the post-translational modification of the 
amino acid arginine to citrulline by the 
enzyme peptidylarginine deiminase 
(PAD). The physiologic role of 
citrullination is unclear; however it has 
been shown to occur during apoptosis, 
and is thought to play a role in the 
degradation of intracellular proteins by 
unfolding protein molecules and thereby 
exposing them to degradation enzymes. 
PAD enzymes can be found in monocytes 
and macrophages associated with 
inflammation, mostly in the synovial 
fluid of patients with RA. Anti-CCP, 
which is found in the serum, is thought to 
be a result of diffusion of these antibodies 
from the synovial fluid into the general 
circulation
Anti CCP-2 antibodies are more 
promising as a diagnostic marker of RA 
and can be used for the diagnosis of early 
RA, prediction of disease severity, 
differentiating RA from other forms of 
non-RA inflammatory or arthritic 
diseases and assessing treatment efficacy.
Anti-CCP antibodies have been 
implicated in RA pathogenesis and hold 
promise for the earlier and more accurate 
diagnosis of RA, and improved 
prognostic information. If the physician is 
to intervene optimally during a patient's 
window of opportunity before irreversible damage 
occurs, such a biomarker may be very useful when 
used in combination with other clinical, radiological 
and laboratory diagnostic features. 
American College of Rheumatology, recommends 
the use of anti-CCP assay as it is a sensitive and more 
specific test than RA-Factor in early as well as fully 
established disease. It also predicts the eventual 
development into RA when found in undifferentiated 
arthritis. It is a marker of erosive disease in RA and 
may be detected in healthy individuals" years before 
the onset of clinical RA.
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Figure 1: Comparison of a healthy and damaged joint as seen in rheumatoid arthritis
Figure 2: Principle of anti-CCP assay in an automated immunoassay analyser
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ADAMTS-13 is an enzyme which is released 
primarily from the stellate cells of liver but is also 
expressed in platelets and endothelial cells. It is 
involved in the regulation of the size of von 
willebrand factor (vWF) in the plasma.  ADAMTS-
13 maintains primary haemostasis by proteolysing 
ultra-large von Willebrand Factor (ULvWF).  The 
latter is the hyperactive form of vWF which is 
released from storage granules (Weibel-Palade 
bodies) of endothelial cells in response to 
inflammatory stimulation. The ULvWF has more 
affinity for platelets favouring platelet aggregation at 
sites of high shear stress with subsequent formation 
of micro vascular thrombi. The ULvWF relies upon 
ADAMTS-13 for its cleavage and its conversion into 
a less active form. 
Deficiency of ADAMTS-13 may be congenital 
(Upshaw-schulman syndrome) or much more 
frequently acquired. An acquired deficiency is 
attributed to the presence of auto-antibodies against 
ADAMTS-13 which may either inhibit ADAMTS-
13 function or may cause rapid clearance of 
circulating ADAMTS-13. Inherited or acquired 
deficiency of ADAMTS-13 impairs ULvWF 
cleavage. Deficient proteolysis of ULvWF results in 
disseminated platelet-rich thrombi in the 
microcirculation which in turn cause typical 
thrombotic micro-angiopathies resulting in end 
organ ischemia.
The laboratory assessment of ADAMTS-13 levels is 
useful since severe deficiency of ADAMTS-13 has 
been proposed as a specific laboratory marker of 
thrombotic thrombocytopenic purpura (TTP) or 
Upshaw-schulman syndrome. It is also seen in 
conditions like sepsis, disseminated intravascular 
coagulation (DIC) and metastatic malignancy. Mild 
to moderate deficiency is seen in chronic 
inflammation, hepatic dysfunction and pregnancy.
Given that severe secondary deficiency of 
ADAMTS-13 might correlate with development of 
widespread microvascular thrombi and end organ 
injury, determination of ADAMTS-13 activity at the 
time of hospital admission in patients with severe 
conditions like sepsis and DIC will help in 
understanding the extent of the disease.  It also raises 
the possibility of novel supportive therapies for 
patients with sepsis and DIC such as ADAMTS-13 
supplementation and plasma therapy because sepsis 
may have the same pathophysiology of severe 
ADAMTS-13 deficiency for  thrombotic  
microangiopathies as idiopathic TTP.
The test is currently offered by clinical laboratories 
of AKUH. It is based on the principle of ELISA 
technique. Two to three mls of blood collected in 
citrate anticoagulant will be required for the test.  
The reference range developed at AKUH for 
ADAMTS-13 is 175-365 ng/dl. There is no 
difference in reference range between males and 
females or adults and children.
1. Nguyen TC, Liu A, Liu L, Ball C, Choi H, May 
WS, et al. Acquired ADAMTS-13  deficiency 
in pediatric patients with severe sepsis. 
Haematologica; 2007; 92(1): 121-4.
2. Mannucci PM, Peyvandi F. TTP and 
ADAMTS13: When Is Testing Appropriate?  
Haematology Am Soc Hematol Educ Program 
2007; 2007:121-6.
3. Ono T, Mimuro J, Madoiwa S, Soejima K, 
Kashiwakura Y, Ishiwata A et al. Severe 
secondary deficiency of von Willebrand 
factor-cleaving protease (ADAMTS13) in 
patients with sepsis-induced disseminated 
intravascular coagulation: its correlation with 
development of renal failure. Blood 2006; 
107:528-34. 
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A Disintegrin and Metallopeptidase with 
Thrombospondin Type 1 Motif, 13 
(ADAMTS-13)
Dr Farheen Karim Mahar
Haemataology
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Anaemia associated with chronic disease and iron 
deficiency comprises the major bulk of all anaemias. 
Differentiation between these two types of anaemias 
and diagnosis of a patient with chronic disease 
having iron deficiency is not very simple as they tend 
to present with similar clinical and laboratory 
features. In recent years, soluble transferrin receptor 
(sTfR) and its ratio to ferritin (sTfR/ferritin) have 
been proposed as useful tools in this regard.
The uptake of iron by cells is mediated by a 
transferrin receptor (TfR) expressed on their external 
surface. TfR binds diferric transferrin, and the 
receptor-transferrin complex is internalised into an 
endosome, where the iron is transferred to the 
cytosol (Figure 1). After recycling to the cell surface, 
the apo-transferrin dissociates, and the receptor is 
free to repeat the process. Cells deficient in iron up-
regulate their expression of TfR to compete more 
successfully for available iron. TfR is a disulfide-
linked dimer of two identical 85-kDa subunits. Each 
subunit has a 61-amino acid N-terminal cytoplasmic 
domain, a transmembrane region, and a large 
extracellular domain. TfR is shed from cells by 
proteolytic cleavage just external to the plasma 
membrane and just after the two interchain disulfide 
bonds. The product circulates in the blood as soluble 
TfR (sTfR), a 74-kDa monomer bound to transferrin. 
The amount of circulating sTfR is proportional to the 
total amount of cell-associated TfR.
The cellular need for more iron causes increased 
expression of TfR, regulated by a mechanism 
involving Iron-Responsive Elements (IRE) of 
mRNA and Iron-Binding Proteins (IBP). IBPs 
change conformation on binding iron; the iron-free 
conformation binds to IREs, modifying mRNA in 
ways that depend on the location of the IRE. In the 
case of TfR mRNA, binding of IBPs stabilizes the 
mRNA, thereby increasing the steady-state 
concentration and increasing the rate of synthesis of 
TfR. Thus, a low concentration of intracellular iron 
leads to increased expression of TfR.
Since most cellular iron utilisation (80 per cent of 
metabolic iron) is by erythroid precursor cells, 
circulating sTfR is proportional to erythroid 
precursor mass (i.e., rate of erythropoiesis). As a 
consequence, sTfR is low in patients with 
hypoplastic anaemias, and high in patients with 
hyperplastic anaemias such as RBC haemolysis or 
chronic blood loss. Similarly, plasma sTfR is high in 
patients who are iron deficient and therefore 
concentration of serum sTfR is useful in the 
diagnosis of iron deficiency, especially in patients 
with chronic inflammatory, infectious, or malignant 
disease, where the usual tests of iron status may be 
misleading. 
It has been established that serum or plasma sTfR is 
elevated by iron deficiency in patients with or 
without chronic disease but is not affected by chronic 
disease in the absence of iron deficiency. In many 
clinical trials, it has been demonstrated that elevated 
sTfR highly correlated with absence of iron in a 
marrow aspirate, is the "gold standard" of iron 
deficiency.
Dr Muhammad Shariq Shaikh
Haematology
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Soluble Transferrin Receptor (sTfR)
Figure 1: Schematic mechanism for the uptake of iron by a cell.
TfR expressed on the cell surface preferentially binds Transferrin (Tf) 
that has two atoms of iron. The Tf-TfR complex is internalized into 
endosomes. The pH of endosomes decreases, facilitationg iron 
dissociation and increasing the affinity of the receptor for apoTf. 
The iron moves to the cytosol, and the endosome recycles to the 
plasma membrane with the Tf-TfR complex. At the higher pH of the 
extracellular fluid, apo-Tf dissociates and is replaced by diferric Tf, 
and the cycle repeats.
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At  AKUH  the  test  is  performed  by 
immunoturbidimetric method on Roche Hitachi 902   
method. The assay operates on the quantitative two-
site immunoenzymometric (sandwich) technique. A 
monoclonal antibody specific for sTfR is pre-coated 
onto the wells of a micro plate. After the addition of 
sample and assay diluents to the wells, it is incubated 
for one hour, during which sTfR becomes bound to 
the immobilised antibody. After any unbound 
material is washed away, a second monoclonal 
antibody conjugated to horseradish peroxidase is 
added and incubated for one hour, during which the 
conjugate binds to the captured sTfR. After another 
washing away of unbound material, the amount of 
bound conjugate is detected by reaction for 30 
minutes with a specific substrate, which yields a 
coloured product that is proportional to the amount 
of conjugate (and thus to the amount of sTfR in the 
sample). The colour reaction is stopped with 
hydrochloric acid, and the concentration of sTfR in 
each well is read from a calibration curve.
In addition to diagnosis of iron deficiency, serum 
sTfR has been used to monitor the rate of 
erythropoiesis. It has been used to follow marrow 
engraftment after bone marrow transplant and to 
categories anaemia as either hyperplastic or 
hypoplastic. 
1. Allen J, Backstrom KR, Cooper JA, Cooper 
MC, Detwiler TC, Essex DW et al. 
Measurement of soluble transferrin receptor in 
serum of healthy adults. Clin Chem. 1998 
Jan; 44(1): 35-9.
2. Vikstedt R, Von Lode P, Takala T, Iriala 
K,Peltola O, Pettersson K, Suominen P. Rapid 
one-step immunofluorometric assay for 
measuring soluble transferrin receptor in 
whole blood. Clin Chem. 2004 Oct; 50 
(10): 1831-3.
References:
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Diagnosis of Cryptococcal Meningitis
Dr Kauser Jabeen
Microbiology
Cryptococcus neoformans is encapsulated 
yeast that is responsible for serious infections 
in immunocompromised population. The 
common predisposing factors include AIDS, 
prolonged treatment with steroids, organ 
transplantation, advanced malignancy, 
diabetes and sarcoidosis.  Lungs and the CNS 
are the most frequently involved sites; 
however any organ can be involved in a 
severely immuno-suppressed host. Accurate 
management of this infection requires a high 
index of suspicion and prompt diagnosis.
Microscopic examination by India ink: It 
is a rapid, cheap and effective method for 
diagnosis of Cryptococcal infections. 
Samples are mixed with a drop of India ink on 
a glass slide and visualised under the 
microscope. The microscopic examination is 
positive in around 80 per cent of HIV and    
50 per cent of non-HIV patients. Yeast could 
be confused with lymphocytes surrounded 
Diagnostic Modalities
Figure 1: India ink preparation of CSF of a patient with meningitis 
showing multiple encapsulated yeasts with budding (white arrow).
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by proteinaceous material. Therefore it is always 
important to visualise budding yeast cells (figure 1).
On Gram staining Cryptococcus are visualised as 
poorly-stained Gram positive yeasts.
Histology:  Tissue biopsies and cytologies both are 
very helpful in the diagnosis of 
cryptococcosis. Cryptococcus 
are visualised in routine 
hematoxylin and eosin (H&E) 
stain as round yeast cells 
surrounded by empty spaces 
(figure 2).  The capsule could 
be stained using mucicarmine 
and alcian blue stain. Gomori's 
methenamine silver (GMS) 
stain could also be used to 
visualise this narrow-based 
budding yeast in the tissue.
Culture:  Cryptococcus 
neoformans could grow on 
most routine bacterial and 
fungal media. This yeast 
usually grows within 3-7 days 
after inoculation of specimen 
on the media. Most of the 
isolates are positive for rapid 
urease test. Final identification 
i s  u s u a l l y  p e r f o r m e d  
biochemically on API yeast. 
DNA-based methods could 
also be performed to identify 
the isolate.
Latex particle agglutination: 
This test detects the presence 
of the polysaccharide capsule 
of the organism in the serum 
and CSF (figure 3). It is a rapid 
and extremely accurate test for 
the diagnosis of Cryptococcal 
infections. It has a sensitivity 
and specificity of greater than 
90 per cent. An additional 
advantage of this test is the 
reporting of polysaccharide 
antigen titer. This information 
could be used as a general 
prognostic indicator as a high 
titer of 1:1024 reflects greater 
chance of therapeutic failure. 
However it should be noted 
that these titers should not be used to make 
therapeutic decisions and the serial polysaccharide 
antigen titers are often imprecise.
All of the above modalities for the diagnosis of 
Cryptococcal infections are available at the clinical 
microbiology laboratory of Aga Khan University.
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Figure 2: Histology of lung of a patient showing multiple pink rounded yeast cells with empty spaces 
suggestive of Cryptococcal infection
Figure3: Latex particle agglutination test for the detection of Cryptococcal capsular antigen. 
Well 5 is showing a positive test with positive and negative controls in Well 1 and 2 respectively.
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Infections in Thalassaemia
Thalassaemia is a heterogeneous group of genetic 
disorders of hemoglobin synthesis characterised by 
a disturbance in the production of globin chains, 
leading to anaemia, ineffective erythropoiesis, and 
premature destruction of red blood cells. 
Clinical severity varies widely ranging from 
asymptomatic forms to severe or even fatal entities. 
In the severe forms of thalassaemia such as, 
Cooley's anaemia or thalassaemia major, the 
abnormal red blood cells processed by the spleen 
and its haematopoietic response to the anaemia lead 
to massive splenomegaly and consequent 
manifestations of hypersplenism, ultimately 
requiring splenectomy. 
Infections are the predominant cause of death in 
these patients accounting for 12-46 per cent of 
overall patient deaths. It is estimated that about 
9,000 children with beta thalassaemia are born 
every year, although no documentary registry is 
available in Pakistan. The estimated carrier rate is 5-
7 per cent, accounting for 9.8 million carriers in the 
total population.
1. Immune abnormalities in thalassaemic 
patients including increased number and activity of 
CD8 suppressor cells, decreased CD4/CD8 ratio, 
C3 and C4 levels along with defective neutrophils, 
macrophages and natural killer cell function.
2. Splenectomy-induced immune abnormalities 
including reduced immune clearance along with 
lower specific antibody responses.
3. Iron overload and bacterial infections: 
Microbial pathogens must obtain growth-essential 
iron from healthy hosts. Some potential pathogens 
however are more dangerous in hosts with iron 
overload. Iron overload causes decreased 
phagocytosis by the monocyte/macrophage system 
and polymorphonuclear leucocytes due to the 
deleterious effects of ferritin associated with iron 
and impairment in immunoglobulin secretion along 
with suppression of complement system function. 
Factors predisposing to infections in these 
patients include:
Organisms such as Yersinia enterocolitica, 
Klebsiella species, Escherichia coli, Streptococcus 
pneumoniae, Pseudomonas aeruginosa, Listeria 
monocytogenes, and Legionella pneumophila have 
increased virulence in vitro in the presence of excess 
iron. Iron overload can also have adverse effects on 
the outcome of viral infections.
Unfor tuna te ly,  desfer r ioxamine therapy  
predisposes to infections by Yersinia spp. The 
virulence enhancing effect of desferrioxamine is 
caused by either due to FoxA receptor that acts as a 
receptor for its active metabolite too or due to its 
partial immunosuppressant effect. Furthermore the 
rate of progression of HIV-1 disease is faster in 
patients with thalassaemia major on low doses of 
desferrioxamine and high serum ferritin 
concentrations and with high bone marrow 
macrophage iron.
Yersinia enterocolitica: Y.enterocolitica is an 
uncommon cause of severe infections in 
thalassaemic patients in the East unlike the West. 
Y. enterocolitica has been associated with 
septicemia, mesenteric lymphadenitis, liver and 
splenic abscesses, and an acute appendicitis like 
syndrome in these patients.
Microbiologic culture remains the standard for 
diagnosis of yersiniosis. Stool is the preferred 
clinical specimen for patients with intestinal 
symptoms. Other specimens which should be 
considered for culture include blood, throat, 
wounds, and specimens obtained at surgery such as 
the appendix or lymph nodes. Serologic tests are 
also widely used for the diagnosis of yersiniosis.
Klebsiella spp: High ferritin level and deranged 
liver function in thalassaemia appears to be the risk 
factors of infections due to Klebsiella spp. The 
diagnosis of K. pneumoniae infection is confirmed 
by culture of blood, sputum, urine, or aspirated body 
fluid. 
Klebsiella spp. typically appears as short, plump, 
Specific infectious agents involved in infection 
include:
Dr Sadia Omer
Microbiology
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gram-negative bacilli, which are usually 
surrounded by a capsule that appears as a clear space. 
They have no specific growth requirement and 
could grow on ordinary media. They are lactose 
fermenters and this property is used for 
identification in microbiology laboratories. 
Salmonella spp.: Salmonellae are motile Gram-
negative bacilli. Salmonella are oxidase negative 
and virtually all are non-lactose fermenters. Most 
laboratories identify Salmonellae by a combination 
of antigenic and biochemical reactions. Suspicious 
colonies are agglutinated using antisera directed 
against specific O (lipopolysaccharide) and H 
(flagellar) antigens that allow identification of the 
serogroup
Escherichia coli: E. coli is Gram-negative, 
facultative anaerobic, non lactose fermenters and 
non-sporulating bacilli. Typically diagnosis is done 
by culturing on MacConkey medium and 
biochemical reactions. Other methods for detecting 
E. coli include ELISA tests, colony immunoblots, 
and direct immunofluorescence microscopy of 
filters, immunocapture techniques and PCR.
Post-splenectomy infections: The incidence of 
severe infections (for example, meningitis, 
pneumonia, sepsis) caused by encapsulated bacteria 
(S pneumoniae, H influenzae type B, N 
meningitidis) is six per cent higher among 
splenectomised patients with thalassaemia 
compared with those individuals splenectomised 
for trauma. Children appear to be at particularly 
high risk. Other pathogens responsible for post-
splenectomy infections include bacteria such as E 
coli, P aeruginosa, group B beta hemolytic 
streptococci, Enterococcus spp, Ehrlichia spp, and 
Plasmodium spp. Blood culture is routinely done for 
the diagnosis of these infections. Several rapid 
diagnostic tests have been developed to aid in the 
diagnosis along with PCR.
Streptococcus pneumoniae has characteristic 
lancet-shaped gram positive diplococci. Like 
Klebsiella spp., they have no specific growth 
requirement. Complementary method to detect 
S.pneumoniae is urinary antigen assays. The test has 
high sensitivity compared to blood cultures and 
sputum studies in patients with bacteremia. Other 
tests including PCR tests for detecting 
pneumococcal autolysin or pneumolysin have been 
developed.
Effective vaccines are available against each of these 
pathogens. It is mandatory for every patient 
undergoing elective splenectomy to have 
Pneumovax, optimally at about 1 month pre-surgery. 
In addition to this immunoprophylaxis other 
measures include chemoprophylaxis with prolonged 
use of antibiotics and patient education to attend 
seriously to any impending fever or infection.
Hepatitis B (HBV) and C virus (HCV) infections are 
a major problem for thalassaemic patients because of 
repeated blood transfusions.  Infection with these 
blood borne viruses is associated with characteristic 
changes in the serum levels of viral antigens and 
antibodies. Diagnostic qualitative and quantitative 
PCR tests for HBV and HCV in serum have been 
developed to assess in diagnosing viral replication.
The availability of vaccines and the introduction of 
the screening of transfused blood units for hepatitis 
Bs antigen (HBsAg) and HCV antibodies have 
reduced the incidence of these infections.
Both á-and â- thalassaemia have been shown to 
afford some protection against P. falciparum malaria 
in keeping with their geographical distribution, but 
the mechanism of protection remains unknown. 
However in case of infection, detection of parasites 
on Giemsa-stained blood smears by light 
microscopy remains the gold standard for diagnosis 
of malaria. Rapid diagnostic tests for detection of 
Plasmodium spp. have been developed. However 
desirable characteristics for RDTs vary depending 
Hepatitis B and C virus
Malaria and á-thalassaemia
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Figure 1: Lancet-shaped gram positive diplococci suggestive of 
Streptococcus pneumonia in a sputum smear
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CDX-2 is a caudal-related homeobox transcription 
factor whose expression in adults is normally 
restricted to the intestinal epithelium. CDX-2 protein 
is responsible for regulating the proliferation and 
differentiation of intestinal epithelial cells and 
therefore it is expressed predominantly, as a nuclear 
marker of epithelial cells, lining the villi and crypts 
in the small and large intestines.  Hence, CDX-2 
protein is a useful marker for intestinal 
adenocarcinomas,  especially  colorectal 
adenocarcinomas.
The differentiation of secondary from primary 
adenocarcinomas of the colorectum is important 
because their clinical management and prognosis are 
different. CDX-2 immunostaining may be useful in 
discriminating primary and metastatic colorectal 
carcinomas from frequent types of adenocarcinomas 
of nongastrointestinal origin, since CDX-2 is 
consistently expressed in more than 90 per 
cent of colorectal carcinomas, while its 
expression is rare in extraintestinal 
adenocarcinomass like breast, lung, thyroid, 
kidney and endometrial adenocarcinomas.  
However, CDX-2 is expressed in 10-30 per 
cent of other gastrointestinal malignancies, 
20-65 per cent of mucinous ovarian tumors 
and 50-100 per cent of urinary bladder 
carcinomas. Compared with villin, a 
p r e v i o u s l y  d e s c r i b e d  m a r k e r  o f  
gastrointestinal adenocarcinoma, CDX-2 
demonstrates superior sensitivity and 
comparable specificity.  
Another important aspect of CDX-2 
expression in colon carcinomas is that CDX-2 
expression is inversely related to the degree of 
anaplasia, therefore loss of CDX-2 protein 
expression has been correlated with loss of 
differentiation in colorectal cancers and hence 
poorly differentiated colorectal carcinomas 
demonstrate a lower frequency of CDX-2 staining 
compared to well and moderately differentiated 
tumors.  Thus, it may have both diagnostic and 
prognostic uses.  
CDX-2 is a reliable, specific, and sensitive 
immunohistochemical marker of normal and 
neoplastic intestinal epithelium and can be easily 
applied to routine histologic and cytologic material. 
It may have both diagnostic and prognostic uses, 
suggesting including of CDX2 in any antibody panel 
to distinguish between primary and secondary 
epithelial colorectal malignancies, as well as 
targeting metastasis from an unknown primary.  
AKUH Laboratory has recently added this marker in 
the immunohistochemistry panel.
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on the epidemiology of infection and goals for 
control in the region where the test is used. 
Molecular technologies are also emerging in 
assisting the diagnosis of malaria.
Early recognition with prompt treatment and 
prevention of predisposing factors are essential in 
the treatment of patients with thalassaemia and 
infection.
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Figure 1:  Colorectal Carcinoma showing diffuse nuclear positivity to CDX-2
January - February 2010, Vol. 35, Issue 1
Over the last two decades neoadjuvant chemotherapy or 
hormonal manipulation has been increasingly used as a 
treatment option in the management of patients with large 
operable breast cancer. The advantage of neoadjuvant 
chemotherapy over adjuvant chemotherapy is that large 
cancers can be down-staged thereby increasing the possibility 
of breast conserving surgery and the response to the treatment 
can also be monitored. There are a number of studies which 
have reported remarkable radiological and pathological 
response with little or no residual tumor following the 
treatment. Such excellent response creates problems in 
localisation and excision of the residual tumor and so imposes 
a challenge for accurate surgery. Complete response at 
imaging does not necessarily implicate a complete 
pathological response and it is not a safe practice to plan 
surgery based on radiological findings alone. It is in these 
cases that localisation of the tumor bed with radiopaque 
markers prior to the institution of chemotherapy may 
facilitate breast conservation surgery with complete excision 
of tumor bed to ensure removal of microscopic disease.
The procedure of radiopaque marker insertion is very simple 
and can be carried out by a radiologist under mammographic 
or ultrasound guidance. After routine prepping and local 
anesthesia a 16-18 gauge lumbar puncture needle is inserted 
into the lesion ideally in the centre and radiopaque metallic 
clip is inserted and the trocar is used to push the marker in 
position. After the insertion of the clip unilateral 
mammogram is obtained to confirm the position of the marker 
(figure 1)
On completion of chemotherapy (figure 2) the surgeons 
reassess to determine the feasibility of breast conservation 
surgery and if the tumor shows a complete response to 
chemotherapy or is impalpable pre-operative guide wire 
localisation for the metallic markers is carried out for marking 
the tumor bed.
In summary implantation of  radiopaque clips in or adjacent 
to carcinoma of breast is useful in tagging the tumor bed prior 
to breast conservation surgery, especially in patients with 
complete radiological and clinical tumor regression 
following neoadjuvant chemotherapy.
12
Radiopaque Metallic Marker Insertion in 
Breast Cancers Prior to Neoadjuvant/
Preoperative Chemotherapy
Dr Shaista Afzal, Dr Gulnaz Shafqat, Dr Imrana Masroor
Radiology
Figure 1: Mammogram before the commencement of 
neoadjuvant chemotherapy Showing the radiopaque clip
Figure 2: Mammogram after the completion of 
neoadjuvant chemotherapy Showing the radiopaque clip 
and the tumour showing partial response 
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thThe 10  International Radiological Conference was 
held from November 7-9, 2009 at the Sheraton Hotel 
in Karachi. The theme of the conference was 
'achieving excellence in radiology practice.' It was 
organised by the Radiological Society of Pakistan 
(RSP).
Participants from all over Pakistan as well as from 
USA, UK, Canada and India attended the conference. 
Papers presented during the conference covered a 
diverse range of topics with discussion of recent 
advancements and methods. 
Very informative and interactive pre-conference 
workshops were arranged for the radiologists, 
trainees and radiographers, covering many 
important aspects of radiology training and 
advancements. On day one several workshops were 
held. 
A basic MRI course was held at the Sheraton hotel. 
The chief organiser, Dr Zafar Sajjad, Associate 
Professor and Interim Chair, Department of 
Radiology, AKUH conducted it with excellence. It 
focused on providing the participants about basic 
knowledge of MRI physics, contrast usage and MR 
imaging of the shoulder, knee, spine and brain.
A hands-on workshop of obstetric/gynae ultrasound 
was organised at Jinnah Post Graduate Medical 
Center (JPMC). It was a very successful and helpful 
workshop that allowed participating radiologists to 
enhance their practical skills, regarding foetal 
doppler ultrasound and placental evaluation.
Another useful pre-conference workshop showed 
participants how to initiate a radiology research 
project. Facilitated by Dr Wasim Akhtar, Assistant 
Professor, Department of Radiology, AKUH, it was 
very appreciated as a number of radiologists needed 
guidance on the initiation of research projects. It 
proved to enhance the basic know-how of the 
participants about radiology research, literature 
research, biostatistics and common errors in paper 
writing.
A workshop session on radiographic critique was 
held at AKUH: it was organized for radiographers, 
regarding quality control, emergency and trauma 
radiography and radiation protection.
On day two, the pre-conference workshops were 
continued and Multi-Detector CT (MDCT) as an 
advanced imaging modality was discussed, during 
the first session. It was focused on orienting the 
participants about MDCT image formation, image 
manipulat ion and contrast del ivery. An  
interpretation session followed the workshop.
Hands-on practice was given to the participants 
during Doppler and Musculoskeletal (MSK) 
ultrasound workshop session, which focused on 
the carotid, peripheral, renal and visceral Doppler, 
as well as providing basic knowledge about MSK 
ultrasound and interpretation.
A workshop on Breast imaging facilitated by
Dr Imrana Masroor, Associate Professor, 
Department of Radiology, AKUH, and her team 
highlighted on breast ultrasound, intervention and 
MRI and mammograms. The workshop was 
interactive and helped the participants to 
understand the basics of breast imaging.
A full-day workshop on Interventional Radiology 
was held at AKUH; Dr Imran Syed, Consultant 
Radiologist, from Queen's Hospital, UK 
conducted the workshop and gave a live 
demonstration of interventional procedures like 
biliary interventions, Peripherally Inserted Central 
Catheter (PICC) and central venous line placement 
and Trans Arterial Chemoembolisation (TACE). 
Hands-on was also given for US guided procedures.
Dr Nai la Nadeem, Assis tant Professor, 
Department of Radiology, AKUH organised a 
workshop on Assessment and feedback to trainees 
during work in radiology. Its main focus was 
assessment of radiology residents during training 
and role of faculty and residents on feedback 
system. 
Dr Azieka Imdad, Muhammad Bilal Ahmad
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The session of video conferencing between UK and 
Pakistan was highly interactive and mainly focused 
on the musculoskeletal imaging, also served as a 
bridge between the Pakistani and the UK-based 
Pakistani consultants.
AKUH radiology actively participated in the 
conference and won prizes. The first prize for best 
paper presentation was won by Dr Zainab Hussain, 
Resident, Department of Radiology, AKUH  while 
the first prize for best poster was won by Mr Mansoor 
Naqvi, Physicist, Department of Radiology, AKUH 
 and second prize by Dr Rana Shoaib, Fellow of  
Radiology, Department of Radiology, AKUH. The 
winners of the conference quiz were Dr Fahd Haroon 
and Dr Mohammed Zeeshan, Resident, Department 
of Radiology, AKUH who jointly received the first 
prize.
Another highlight of the conference was the cultural 
evening and banquet dinner held on November 9. It 
was well attended and was very refreshing for the 
participants of the conference, with music served as a 
food for the soul.
The conference concluded on November 9 with the  
distribution of certificates and souvenirs among the 
organisers and participants. Efforts of scientific 
committee were commendable under the leadership 
of Dr Tanveer-ul-Haq who was fully supported by 
president of the RSP, Dr. M. Nadeem Ahmad and    
Dr Zafar Sajjad.
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On December 9, the Clinical Laboratory arranged a 
Continuous Medical Education Seminar at AKU 
auditorium on “Assessing and Managing 
Osteoporosis”. It was the first time at AKU that this 
CME was seen by all AKHSP via Elluminate Live! 
The seminar was a unique experience and a 
successful one as questions and answers were 
exchanged between AKHSP audience and speakers.
Dr Farooq Ghani, Associate Professor and 
Consultant Pathologist, Department 
of Pathology & Microbiology, 
AKUH, gave the opening statement 
followed by a presentation by        
Dr Aysha Habib Khan, Assistant 
P r o f e s s o r  a n d  C o n s u l t a n t  
Pathologis t ,  Depar tment  of  
Pathology and Microbiology, 
AKUH, on osteoporosis and its 
assessment. She highlighted the risk 
factors leading to osteoporosis and 
showed concerns about patients 
with fractures not being evaluated 
for osteoporosis. Dr Romaina Iqbal, 
Assistant Professor and Consultant 
Nutr i t ionist ,  Department  of  
Community Health Sciences and 
Medicine, AKUH, enlightened the 
audience about taking healthy food to avoid calcium 
deficiency. Dr Jaweed Akhtar, Associate Professor 
and Consultant Endocrinologist, Department of 
Medicine, AKUH, talked about pharmacological 
management of osteoporosis, and discussed 
different therapies for osteoporosis with their pros 
and cons. Mr Asim Mahmood, Physiotherapist, 
Department of Physiotherapy, AKUH, emphasised 
on different exercises which helps in correcting 
postures.
Ms Seema Vaqar
Continuing Medical Education Seminar 
Organised by Clinical Laboratory at AKUH
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